Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CTLA-4Ig is finally making it: a personal perspective

Jeffrey A Bluestone

    American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
    |February 15, 2005
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pharmacology and nonclinical development of teplizumab, a first-in-class immunotherapy for delaying the onset of type 1 diabetes.

    The Journal of pharmacology and experimental therapeutics·2026
    Same author

    Gene-corrected regulatory T cell therapy for IL2RA deficiency.

    Molecular therapy : the journal of the American Society of Gene Therapy·2025
    Same author

    The 2025 Nobel Prize in Physiology or Medicine - a bridge to peripheral immune tolerance.

    The Journal of clinical investigation·2025
    Same author

    Receptor-tethered orthogonal IL-2 enhances regulatory T cell therapy.

    bioRxiv : the preprint server for biology·2025
    Same author

    Transcriptional fingerprinting of regulatory T cells: ensuring quality in cell therapy applications.

    Frontiers in immunology·2025
    Same author

    Second generation CD2-targeting LFA-3 fusion protein SBT115301 to restore immune homeostasis in autoimmune disease.

    iScience·2025